πŸ‡ΊπŸ‡Έ FDA
Patent

US 8603468

Neutralization of HCV

granted A61KA61K2039/545A61K2039/55566

Quick answer

US patent 8603468 (Neutralization of HCV) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Dec 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Dec 10 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K2039/545, A61K2039/55566, A61K39/12, A61K39/29